These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 32340613)

  • 21. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway.
    Guo JQ; Li SJ; Guo GX
    Dig Dis Sci; 2017 Aug; 62(8):2004-2010. PubMed ID: 28451917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Zhang Y; Meng W; Cui H
    Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
    Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
    Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma.
    Hao F; Mou Y; Zhang L; Wang S; Yang Y
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29654169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of lncRNA AFAP1-AS1 suppressed lung cancer development by regulatory mechanism in
    Peng B; Liu A; Yu X; Xu E; Dai J; Li M; Yang Q
    Oncotarget; 2017 Nov; 8(55):93608-93623. PubMed ID: 29212176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
    Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
    J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
    Liu RH; Wang MY; Chen LY; Yin ZJ; Ji QK; Wang YY; Jin BZ
    Oncotarget; 2018 Jan; 9(8):8100-8110. PubMed ID: 29487718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
    Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
    Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR-146b-5p and lncRNA-AFAP1-AS1.
    Zhou J; Liu M; Chen Y; Xu S; Guo Y; Zhao L
    J Cell Physiol; 2019 Apr; 234(4):4655-4667. PubMed ID: 30206930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.
    Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S
    Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
    Chen R; Cheng Y; Zhang Y; Li Z; Geng L
    Int J Gynecol Cancer; 2014 Feb; 24(2):184-91. PubMed ID: 24457551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W; Li N; Kang X; Shi K
    Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA AFAP1-AS1 accelerates invasion and predicts poor prognosis of glioma.
    Wang Y; Lan Q
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5223-5229. PubMed ID: 30178845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.